Cargando…
Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA
BACKGROUND: The intravitreal anti-vascular endothelial growth factor treatments ranibizumab and aflibercept have proven efficacy in clinical trials, but their real world usage in central retinal vein occlusion (CRVO) has not been assessed. We therefore evaluated the treatment patterns of both drugs...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366471/ https://www.ncbi.nlm.nih.gov/pubmed/25572584 http://dx.doi.org/10.1038/eye.2014.308 |